Sleep Hygiene and Relaxation Exercises for Anxiety and Sleep Quality in Type 2 Diabetes
sleep hygiene education and progressive relaxation exercise
Mental Disorders+9
+ Diabetes Mellitus
+ Diabetes Mellitus, Type 2
Supportive Care Study
Summary
Study start date: May 15, 2025
Actual date on which the first participant was enrolled.This study is exploring how teaching good sleep habits and using relaxation exercises can help people with Type 2 Diabetes manage their anxiety, improve sleep quality, and control their blood sugar levels. Sleep problems are common in people with diabetes and can make managing the condition even harder. Poor sleep can lead to increased blood sugar levels and difficulties with insulin. The study aims to show how non-drug approaches, like sleep hygiene education and progressive relaxation exercises, can be beneficial in managing these issues, potentially leading to better overall health and less reliance on medications. Participants in the study will receive education on how to improve their sleep, such as setting sleep routines, avoiding caffeine before bed, and engaging in calming activities. They will also practice progressive relaxation exercises, which involve tensing and then relaxing different muscle groups to reduce stress. The study will measure changes in anxiety levels, sleep quality, and blood sugar control to see if these methods are effective. By participating, individuals may experience improved sleep and reduced anxiety, potentially leading to better management of their diabetes. The study highlights the importance of these non-drug methods and their potential benefits for people with diabetes.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.52 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Supportive Care Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 64 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives